Literature DB >> 18075673

Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity.

Mark R Wilson1, Justin J Yerbury, Stephen Poon.   

Abstract

The in vivo formation of fibrillar proteinaceous deposits called amyloid is associated with more than 40 serious human diseases, collectively referred to as protein deposition diseases. In many cases the amyloid deposits are extracellular and are found associated with newly identified abundant extracellular chaperones (ECs). Evidence is presented suggesting an important regulatory role for ECs in amyloid formation and disposal in the body. A model is presented which proposes that, under normal conditions, ECs stabilize extracellular misfolded proteins by binding to them, and then guide them to specific cell receptors for uptake and subsequent degradation. Thus ECs and their receptors may be critical parts of a quality control system to protect the body against dangerously hydrophobic proteins/peptides. However, it also appears possible that in the presence of a high molar excess of misfolded protein, such as might occur during disease, the limited amounts of ECs available may actually exacerbate pathology. Further advances in understanding of the mechanisms that control extracellular protein folding are likely to identify new strategies for effective disease therapies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18075673     DOI: 10.1039/b712728f

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  48 in total

1.  Mutations can cause light chains to be too stable or too unstable to form amyloid fibrils.

Authors:  Marta Marin-Argany; Jofre Güell-Bosch; Luis M Blancas-Mejía; Sandra Villegas; Marina Ramirez-Alvarado
Journal:  Protein Sci       Date:  2015-09-07       Impact factor: 6.725

2.  Association of cerebrospinal fluid Aβ42 with A2M gene in cognitively normal subjects.

Authors:  Steven P Millard; Franziska Lutz; Ge Li; Douglas R Galasko; Martin R Farlow; Joseph F Quinn; Jeffrey A Kaye; James B Leverenz; Debby Tsuang; Chang-En Yu; Elaine R Peskind; Lynn M Bekris
Journal:  Neurobiol Aging       Date:  2013-09-04       Impact factor: 4.673

Review 3.  Misfolded proteins in Alzheimer's disease and type II diabetes.

Authors:  Alaina S DeToma; Samer Salamekh; Ayyalusamy Ramamoorthy; Mi Hee Lim
Journal:  Chem Soc Rev       Date:  2011-08-04       Impact factor: 54.564

Review 4.  Interplay of endoplasmic reticulum stress and autophagy in neurodegenerative disorders.

Authors:  Yu Cai; Jyothi Arikkath; Lu Yang; Ming-Lei Guo; Palsamy Periyasamy; Shilpa Buch
Journal:  Autophagy       Date:  2016       Impact factor: 16.016

Review 5.  Protein folding and aggregation in bacteria.

Authors:  Raimon Sabate; Natalia S de Groot; Salvador Ventura
Journal:  Cell Mol Life Sci       Date:  2010-04-01       Impact factor: 9.261

6.  Systemic hyperfibrinolysis after trauma: a pilot study of targeted proteomic analysis of superposed mechanisms in patient plasma.

Authors:  Anirban Banerjee; Christopher C Silliman; Ernest E Moore; Monika Dzieciatkowska; Marguerite Kelher; Angela Sauaia; Kenneth Jones; Michael P Chapman; Eduardo Gonzalez; Hunter B Moore; Angelo D'Alessandro; Erik Peltz; Benjamin E Huebner; Peter Einerson; James Chandler; Arsen Ghasabayan; Kirk Hansen
Journal:  J Trauma Acute Care Surg       Date:  2018-06       Impact factor: 3.313

Review 7.  Systemic amyloidoses.

Authors:  Luis M Blancas-Mejía; Marina Ramirez-Alvarado
Journal:  Annu Rev Biochem       Date:  2013-02-28       Impact factor: 23.643

8.  Computational modeling of the relationship between amyloid and disease.

Authors:  Damien Hall; Herman Edskes
Journal:  Biophys Rev       Date:  2012-09

9.  GPI anchoring facilitates propagation and spread of misfolded Sup35 aggregates in mammalian cells.

Authors:  Jonathan O Speare; Danielle K Offerdahl; Aaron Hasenkrug; Aaron B Carmody; Gerald S Baron
Journal:  EMBO J       Date:  2010-01-07       Impact factor: 11.598

Review 10.  Protein-based biomarkers in cerebrospinal fluid and blood for Alzheimer's disease.

Authors:  Yongyao Fu; Deming Zhao; Lifeng Yang
Journal:  J Mol Neurosci       Date:  2014-06-25       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.